// App-Quantinova.ai

: APOL1 Genetic Variants Are Associated with Increased Risk of Coronary Artery Disease and Sudden Cardiac Death: An Autopsy Study in Sudden Death Registry

Researchers

Presenter

  • LiangGuo

Principal Investigators

  • MarcoDelsante

  • AnneCornelissen

  • XiaoqingZhao

  • FrankDavidKolodgie

  • MyungShin

  • MaartenHoek

  • JeffreyB.Kopp

  • AviZ.Rosenberg

  • HarryR.Davis

  • RenuVirmani

  • AlokeFinn

Medical Centers

  • CVPath Institute, Gaithersburg, Maryland, United States

  • University Hospital of Parma, Parma, Italy

  • Merck & Co., Inc., Kenilworth, NJ, United States,

  • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ

  • John Hopkins University, Baltimore, Maryland, United States

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Cardiac arrest

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved